Sumer, S. Et Al. 2013. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. HEPATITIS MONTHLY , vol.13, no.6 .

Sumer, S., DEMIR, N. A., Kolgelier, S., İNKAYA, A. Ç., Arpaci, A., DEMIR, L. S., ... Ural, O.(2013). The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. HEPATITIS MONTHLY , vol.13, no.6.

Sumer, Sua Et Al. "The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis," HEPATITIS MONTHLY , vol.13, no.6, 2013

Sumer, Sua Et Al. "The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis." HEPATITIS MONTHLY , vol.13, no.6, 2013

Sumer, S. Et Al. (2013) . "The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis." HEPATITIS MONTHLY , vol.13, no.6.

@article{article, author={Sua Sumer Et Al. }, title={The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis}, journal={HEPATITIS MONTHLY}, year=2013}